WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Roche

RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

www.roche.com.

Roche RSS Channel

Filters
List of articles in category Roche
Title Published Date
For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices 14 September 2015
"Roche Continents" fosters innovation in science and art 11 August 2015
Roche employees unite to raise funds for children in need 16 June 2015
Roche reports strong sales growth in the first quarter of 2015 23 April 2015
Roche acquires Signature Diagnostics to advance translational research for next generation sequencing (NGS) diagnostics 11 February 2015
Roche acquires Trophos to expand portfolio in neuromuscular disease with high medical need 20 January 2015
Roche enters a broad strategic collaboration with Foundation Medicine in the field of molecular information in oncology 12 January 2015
Roche to invest 450 million Swiss Francs in new diagnostic manufacturing facility in China 05 November 2014
Roche delivers solid sales growth for the first nine months of 2014 19 October 2014
Roche again ranked most sustainable healthcare company in the Dow Jones Sustainability Indices 14 September 2014
Roche and InterMune reach definitive merger agreement 25 August 2014
FDA approves Roche's Avastin plus chemotherapy for treatment of advanced cervical cancer 18 August 2014
Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines 05 August 2014
Roche announces definitive agreement to acquire Seragon Pharmaceuticals 02 July 2014
Roche Children's Walk 2014 19 June 2014
Roche with good start in 2014 15 April 2014
Roche delivers strong 2013 results 31 January 2014
Roche and Polyphor join efforts to combat multi-drug-resistant bacterial infections 04 November 2013
Roche posts strong sales growth in the first nine months of 2013 17 October 2013
Roche inaugurates Translational and Clinical Research Center at the Alexandria Center for Life Science in New York City 09 October 2013
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End

Business & Industry

  • Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19
  • Bayer transforms pharma business through breakthrough innovation in healthcare
  • Valneva in advanced discussions with European Commission to supply up to 60 million doses of inactivated, adjuvanted COVID-19 vaccine candidate
  • An in vitro study shows Pfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with a mutation associated with rapid transmission
  • European Commission authorizes COVID-19 vaccine Moderna in Europe

Research & Development

  • New England Journal of Medicine publishes COVID-19 treatment trial results
  • Scientists identify 'immune cop' that detects SARS-CoV-2
  • New findings help explain how COVID-19 overpowers the immune system
  • New virtual screening strategy identifies existing drug that inhibits COVID-19 virus
  • Sustained cellular immune dysregulation in individuals recovering from COVID-19
  • How SARS-CoV-2 interacts with cells
  • Neutralizing antibodies protect against severe COVID-19

Conferences & Events

  • CPhI Worldwide to return in 2021
  • Reuters Events' Cell & Gene Therapy USA
  • Total health: Build a better healthcare system
  • Don't fall for the 'next best action' trap
  • Locking down shape-shifting spike protein aids development of COVID-19 vaccine
  • COVID-19 vaccine innovation could dramatically speed up worldwide production
  • Wearable Injectors and Connected Devices Conference 2020

Regulatory Affairs

  • EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
  • FDA takes additional action in fight against COVID-19 by issuing Emergency Use Authorization for second COVID-19 vaccine
  • Update on assessment of the BioNTech and Pfizer BNT162b2 vaccine marketing authorisation application
  • FDA takes key action in fight against COVID-19 by issuing Emergency Use Authorization for first COVID-19 vaccine
  • EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2
  1. You are here:  
  2. Home
  3. Roche
  4. Divestment of four Roche pharmaceutical products to Meda

About

  • Home
  • Advertise
  • Privacy
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2021. All Rights Reserved.